SCHEMBL6277118

SCHEMBL6277118

CCOC(=O)COc1ccc2c(O)c(OCC=C(C)CCC=C(C)C)c(=O)oc2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 2/20 0.51
▸ MAOA P21397 1/20 0.51
▸ KDM4E B2RXH2 10/20 0.50
▸ ALDH1A1 P00352 9/20 0.50
▸ HPGD P15428 9/20 0.50
▸ HSD17B10 Q99714 7/20 0.50
▸ ALOX15 P16050 5/20 0.50
▸ TDP1 Q9NUW8 4/20 0.50
▸ MAPT P10636 4/20 0.50
▸ CYP3A4 P08684 3/20 0.50
▸ MAPK1 P28482 3/20 0.50
▸ GLA P06280 2/20 0.50
▸ NDUFS8 O00217 1/20 0.50
▸ COXFA4 O00483 1/20 0.50
▸ NDUFAB1 O14561 1/20 0.50
▸ NDUFA1 O15239 1/20 0.50
▸ NDUFS4 O43181 1/20 0.50
▸ NDUFB5 O43674 1/20 0.50
▸ NDUFB3 O43676 1/20 0.50
▸ NDUFC1 O43677 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6277111 1.00 MAOB (0.51) MAOBMAOAKDM4EALDH1A1HPGD
SCHEMBL6277069 0.93 GAA (0.52) MAOBMAOAKDM4EALDH1A1HPGD
SCHEMBL6277075 0.93 GAA (0.52) MAOBMAOAKDM4EALDH1A1HPGD
SCHEMBL8488507 0.90 ALOX15 (0.58) MAOBMAOAKDM4EALDH1A1HPGD
SCHEMBL8488498 0.90 ALOX15 (0.58) MAOBMAOAKDM4EALDH1A1HPGD
SCHEMBL6272547 0.89 MAOB (0.54) MAOBMAOAKDM4EALDH1A1HPGD
SCHEMBL6272555 0.89 MAOB (0.54) MAOBMAOAKDM4EALDH1A1HPGD
SCHEMBL8490417 0.89 ALOX15 (0.62) MAOBMAOAKDM4EALDH1A1HPGD
SCHEMBL6276227 0.86 MAOB (0.54) MAOBMAOAKDM4EALDH1A1HPGD
SCHEMBL6276230 0.86 MAOB (0.54) MAOBMAOAKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1273578-B1 Benzopyran derivatives and antiallergic agent containing the same DAINIPPON INK & CHEMICALS (JP) 2005-02-23 — — EP disclosed
US-6670391-B2 For inhibiting both immediate and delayed type allergic reactions; side effect reduction DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-12-30 — — US disclosed
US-20030096860-A1 Benzopyran derivative and antiallergic agent DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-05-22 — — US disclosed
EP-1273578-A1 Benzopyran derivatives and antiallergic agent containing the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-01-08 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030096860-A1 Benzopyran derivative and antiallergic agent HRH2, HRH1, HRH4 MAOB 1155/4885MAOA 665/4885KDM4E 965/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback